{"id":23,"date":"2026-08-29T12:38:50","date_gmt":"2026-08-29T16:38:50","guid":{"rendered":"https:\/\/pauseproof.com\/articles\/doctor-said-too-young-perimenopause\/"},"modified":"2026-09-13T05:11:18","modified_gmt":"2026-09-13T09:11:18","slug":"doctor-said-too-young-perimenopause","status":"publish","type":"post","link":"https:\/\/pauseproof.com\/articles\/doctor-said-too-young-perimenopause\/","title":{"rendered":"Told You Are Too Young for Perimenopause? What the Guidelines Actually Say"},"content":{"rendered":"\n

If you are 41 and were told you are too young for perimenopause, the guidance does not straightforwardly support that, but it also does not straightforwardly contradict it.<\/strong> NICE guideline NG23 treats the 40 to 45 age band differently from the over 45s, and for your age it actually recommends considering a blood test rather than dismissing the question.<\/p>\n\n\n\n

That distinction is worth knowing precisely, because going back with the wrong version of it will not help you.<\/p>\n\n\n\n

What does NICE actually say, by age?<\/h2>\n\n\n\n

NICE guideline NG23, Menopause: identification and management<\/a>, was last updated on 7 November 2024. It splits by age, and the split is the whole point.<\/p>\n\n\n\n

Your age<\/th>How perimenopause is identified<\/th>Is a blood test part of it?<\/th><\/tr><\/thead>
Under 40<\/strong><\/td>Menopause suspected on clinical grounds<\/td>Yes, serum FSH may be used where menopause is suspected<\/td><\/tr>
40 to 45<\/strong><\/td>Menopause associated symptoms, including a change in the menstrual cycle<\/td>Yes. NICE says consider serum FSH to confirm<\/strong><\/td><\/tr>
45 and over<\/strong><\/td>Recently started vasomotor symptoms plus any change in the menstrual cycle<\/td>Not required. NG23 rec 1.3.1 identifies it without laboratory tests in otherwise healthy people<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Read the middle row again, because it cuts against the way this is usually framed online. For a 41 year old, NICE recommendation 1.3.6 says to consider<\/em> a serum FSH test. A doctor who orders one for you at 41 is following the guideline, not ignoring it. The common claim that NICE recommends against FSH testing is about a different age group, and repeating it will not strengthen your case.<\/p>\n\n\n\n

One further nuance, since it is a genuine source of confusion, and one this page previously got wrong. When this article was first published it said the 2015 version of NG23 contained wording against using FSH in women over 45 and that the November 2024 update changed it. Checked again on 13 September 2026, that does not hold. The current recommendations identify perimenopause and menopause without laboratory tests in otherwise healthy people aged 45 or over, list the tests not to use at that age as anti-M\u00fcllerian hormone, inhibin A, inhibin B, oestradiol, antral follicle count and ovarian volume, and reserve the explicit instruction not to use an FSH test for people using combined oestrogen and progestogen contraception or high dose progestogen. The approach for the over 45s, no laboratory tests, was already the approach in 2015. What the 2024 update changed was mainly the language, from diagnosing women to identifying menopause in people, with the boundary now written as 45 or over.<\/p>\n\n\n\n

\"Woman
What you bring matters more than how well you argue.<\/figcaption><\/figure>\n\n\n\n

Is being dismissed actually common?<\/h2>\n\n\n\n

Here the honest answer is that the evidence is thinner than the internet implies, and it is worth being precise rather than reaching for a statistic that does not exist.<\/p>\n\n\n\n

No source could be found that measures how often women are told they are too young for perimenopause.<\/strong> If you see a percentage attached to that specific claim, treat it with suspicion. What does exist is adjacent and still useful.<\/p>\n\n\n\n